Combatting COVID-19 with Virtual Care and Predictive Analytics
In response to COVID-19, healthcare is reconfiguring itself in real-time by turning to virtual care delivery platforms to treat and screen patients, and data and analytics to track disease spread, predict severity and allocate resources. This article focuses on the role of health IT startups in meeting these expanded service demands with proven but under-utilized tech-based solutions that can scale quickly and massively.
Jill Frew leads Cain Brothers, a division of KeyBanc Capital Markets’ healthcare technology practice, specializing in software/SaaS businesses targeting the payer, provider, consumer and pharma markets. Ms. Frew joined Cain Brothers in 2006 and has over 25 years of experience advising both public and private companies in a variety of M&A, capital raising, and strategic advisory transactions. Ms. Frew has executed transactions across several healthcare verticals, including managed care, provider and pharma services, fintech and HCIT. During her career Ms. Frew has represented or sold companies to American Well, Guidewell, Avizia, CVS, RedCard Systems, Cytel, Cognizant, HealthHelp, WNS, Baxter, Premier Healthcare Exchange (nka Zelis Healthcare), Reed Group, Omnicom Group, Guardian Life Insurance, Cardinal Health, UnitedHealth, Bracket Global and Stanley Black & Decker. In addition, Ms. Frew has recently led successful recapitalizations with many leading financial sponsors.
Ms. Frew began her investment banking career at Wachovia Corporation as an Analyst in the M&A Group. She then went on to work in the investment banking group of Wheat First Securities, where she focused on M&A advisory work and public offerings for clients, primarily in the healthcare industry. Ms. Frew then spent three years as head of the Corporate Development group of PhyAmerica, where she led the M&A activity for this $1 billion healthcare services conglomerate that consummated approximately 100 acquisitions during Ms. Frew’s tenure. In 1995, Ms. Frew co-founded Townsend Frew & Co., a healthcare-focused M&A boutique that was later acquired by Edgeview Partners.
Ms. Frew earned a BS in Finance from Utah State University and an MBA from The College of William & Mary.
David Johnson is the CEO of 4sight Health, a thought leadership and advisory company working at the intersection of strategy, economics, innovation and capital formation. Dave wakes up every morning trying to fix America’s broken healthcare system. Prior to founding 4sight Health in 2014, Dave had a long and successful career in healthcare investment banking. He is a graduate of Colgate University and earned a Masters in Public Policy from Harvard Kennedy School. Employing his knowledge and experience in health policy, economics, statistics, behavioral finance, disruptive innovation, organizational change and complexity theory, Dave writes and speaks on pro-market healthcare reform. His most recent book, The Customer Revolution in Healthcare: Delivering Kinder, Smarter, Affordable Care for All (McGraw-Hill 2019), and many other commentaries are available on www.4sighthealth.com.